Evidence map›Paper›PMID 20919659›Full record

ReviewAdvances in experimental medicine and biology2010

Sphingolipids in parasitic protozoa.

Kai Zhang, James D Bangs, Stephen M Beverley

Open access · greenAbstract readReview
In one paragraph

Review in Advances in experimental medicine and biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
29.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. A broadly active fucosyltransferase LmjFUT1 whose mitochondrial localization and activity are essential in parasiticProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  7. Evaluation of possible prophylactic and therapeutic effect of mefloquine on experimental cryptosporidiosis in immunocompromised mice.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Frontiers in microbiology · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Kai ZhangDepartment of Biological Sciences, Texas Tech University, Lubbock, USA.
James D Bangs
Stephen M Beverley
Texas Tech University · USUniversity of Wisconsin–Madison · USWashington University in St. Louis · US

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
TRANSGENICS COREP60DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 1986 to 2012
$25.2M
YOGA LIFESTYLE INTERVENTION REDUCES BLOOD PRESSURE IN HIV-INFECTED ADULTSP41RR000954 · NCRR · WASHINGTON UNIVERSITY · PI GROSS, MICHAEL L · 1985 to 2011
$16.0M
GLYCOSYLATION MUTANTS OF LEISHMANIAR01AI031078 · NIAID · WASHINGTON UNIVERSITY · PI BEVERLEY, STEPHEN M · 1992 to 2019
$11.4M
MOLECULAR GENETICS OF LEISHMANIA USING DNA TRANSFECTIONR01AI029646 · NIAID · WASHINGTON UNIVERSITY · PI BEVERLEY, STEPHEN M · 1990 to 2015
$9.3M
Secretory Protein Trafficking and Folding in African TrypanosomesR01AI035739 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI BANGS, JAMES D. · 2000 to 2020
$6.6M
MECHANISM OF GENE AMPLIFICATION IN LEISHMANIAR01AI021903 · NIAID · WASHINGTON UNIVERSITY · PI BEVERLEY, STEPHEN M · 1985 to 2010
$2.6M
DRUG RESISTANCE AND GENE AMPLIFICATION IN LEISHMANIAR37AI021903 · NIAID · WASHINGTON UNIVERSITY · PI BEVERLEY, STEPHEN M · 1993 to 2002
$960k
Roles of Plasmenylethanolamine Biosynthesis in Leishmania virulenceR15AI076909 · NIAID · TEXAS TECH UNIVERSITY · PI ZHANG, KAI · 2008 to 2008
$206k
NCRR NIH HHS P41 RR000954NCRR NIH HHS P41-RR00954NIAID NIH HHS R01 AI021903NIAID NIH HHS R01 AI029646NIAID NIH HHS R01 AI031078NIAID NIH HHS R01AI031078NIAID NIH HHS R01 AI035739NIAID NIH HHS R01-AI35739NIAID NIH HHS R15 AI076909NIAID NIH HHS R15AI076909NIDDK NIH HHS P30 DK056341NIDDK NIH HHS P30-DK56341NIDDK NIH HHS P60 DK020579NIDDK NIH HHS P60-DK20579
6 · The paper itself

Abstract

The surface of most protozoan parasites relies heavily upon lipid-anchored molecules, to form protective barriers and play critical functions required for infectivity. Sphingolipids (SLs) play important roles through their abundance and involvement in membrane microdomain formation, as well as serving as the lipid anchor for many of these molecules and in some but possibly not all species, as important signaling molecules. Interactions of parasite sphingolipid metabolism with that of the host may potentially contribute to parasite survival and/or host defense. In this chapter we summarize current knowledge of SL structure, synthesis and function in several of the major parasitic protozoan groups.

Indexed as

AnimalsGiardia lambliaHumansLeishmaniaParasitesPlasmodium falciparumSphingolipidsToxoplasmaTrichomonas vaginalisTrypanosomaSphingolipids

Identifiers

PMID20919659
PMCPMC2951629
OpenAlexW36046902

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.